The investigational vaccine was developed by the Modern biotechnology company and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial will take place at nearly 100 research sites in the U.S., according to Moderna. The first patient was dosed at a site …
Read More »Coronavirus Vaccine: First Phase 3 Clinical Trial Begins in the United States
